1. Home
  2. RVLV vs GALT Comparison

RVLV vs GALT Comparison

Compare RVLV & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

HOLD

Current Price

$31.30

Market Cap

2.1B

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.45

Market Cap

261.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVLV
GALT
Founded
2003
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
261.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
RVLV
GALT
Price
$31.30
$3.45
Analyst Decision
Buy
Strong Buy
Analyst Count
13
3
Target Price
$26.42
$8.50
AVG Volume (30 Days)
1.1M
804.0K
Earning Date
02-24-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
35.78
N/A
EPS
0.78
N/A
Revenue
$1,195,039,000.00
N/A
Revenue This Year
$8.95
N/A
Revenue Next Year
$6.42
N/A
P/E Ratio
$39.17
N/A
Revenue Growth
9.24
N/A
52 Week Low
$16.80
$1.07
52 Week High
$34.15
$7.13

Technical Indicators

Market Signals
Indicator
RVLV
GALT
Relative Strength Index (RSI) 68.89 29.48
Support Level $29.56 $3.90
Resistance Level $31.48 $4.35
Average True Range (ATR) 1.09 0.48
MACD -0.06 -0.15
Stochastic Oscillator 92.96 3.03

Price Performance

Historical Comparison
RVLV
GALT

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: